SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,983 | -11.7% | 21,472 | -3.8% | 0.09% | -5.5% |
| Q2 2023 | $670,609 | -17.0% | 22,309 | 0.0% | 0.09% | -38.1% |
| Q1 2023 | $808,255 | +1.6% | 22,309 | 0.0% | 0.15% | -3.3% |
| Q4 2022 | $795,762 | -6.5% | 22,309 | +4.5% | 0.15% | +23.6% |
| Q4 2017 | $851,000 | -0.4% | 21,344 | 0.0% | 0.12% | -3.1% |
| Q3 2017 | $854,000 | -7.2% | 21,344 | 0.0% | 0.13% | -67.7% |
| Q2 2017 | $920,000 | +1252.9% | 21,344 | +888.6% | 0.39% | +379.3% |
| Q1 2017 | $68,000 | -99.9% | 2,159 | 0.0% | 0.08% | -91.7% |
| Q4 2016 | $54,514,000 | – | 2,159 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |